Cargando…
An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease
METHODS: In a 12-week, open-label, exploratory clinical trial, 126 NAFLD patients were randomly divided into the GLS group (lifestyle intervention plus GLS) or the polyene phosphatidylcholine (PPC) group (lifestyle intervention plus PPC). Random numbers generated by DPS software were used in combina...
Autores principales: | Zhang, Yang, Luo, Jian-Xing, Li, Yan-Ge, Fu, Hong-Fang, Yang, Fang, Hu, Xiao-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967510/ https://www.ncbi.nlm.nih.gov/pubmed/35368766 http://dx.doi.org/10.1155/2022/4583645 |
Ejemplares similares
-
A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples
por: Li, Qiao, et al.
Publicado: (2018) -
A study on the processing technology for Rhizoma Coptidis
por: Wang, Yunhong, et al.
Publicado: (2022) -
Separation and Enrichment of Alkaloids from Coptidis Rhizoma and Euodiae Fructus by Macroporous Resin and Evaluation of the Effect on Bile Reflux Gastritis Rats
por: Li, Yan-Ying, et al.
Publicado: (2022) -
Simultaneous Qualitative and Quantitative Evaluation of the Coptidis Rhizoma and Euodiae Fructus Herbal Pair by Using UHPLC-ESI-QTOF-MS and UHPLC-DAD
por: Li, Yan-Ying, et al.
Publicado: (2020) -
Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology
por: Yang, Yatian, et al.
Publicado: (2023)